Investing in Antibiotics to Alleviate Future Catastrophic Outcomes: What Is the Value of Having an Effective Antibiotic to Mitigate Pandemic Influenza?

Health Economics - United States
doi 10.1002/hec.3867
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Wiley

Related search

Adaptive Vaccination Strategies to Mitigate Pandemic Influenza: Mexico as a Case Study

PLoS ONE
Multidisciplinary
2009English

The Effective Reproduction Number of Pandemic Influenza

Epidemiology
Epidemiology
2010English

Simulating School Closure Strategies to Mitigate an Influenza Epidemic

Journal of public health management and practice : JPHMP
Health PolicyPublic HealthOccupational HealthEnvironmental
2010English

Reply to Abat Et Al.: Improved Policies Necessary to Ensure an Effective Future for Antibiotics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Capacity of Thailand to Contain an Emerging Influenza Pandemic

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2009English

What Is a Pandemic?

JAMA - Journal of the American Medical Association
Medicine
2019English

Critical Issues in Responding to Pandemic Influenza

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2006English

An In-Vitro Study to Find the Antibiotic Susceptibility of Aggregatibacter Actinomycetocomitans to Various Antibiotics

Biomedical Journal of Scientific & Technical Research
2018English

The Age Distribution of Mortality Due to Influenza: Pandemic and Peri-Pandemic

BMC Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy